Documents | Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion | Guidance

A list of downloadable documents created during development.

Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion

Background information

Macular oedema (retinal vein occlusion) - dexamethasone: review decision - January 2015 information

Macular oedema (retinal vein occlusion) - dexamethasone: appendix A 26 January 2015 76.62 KB

Macular oedema (retinal vein occlusion) - dexamethasone: review proposal November 2014 information

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix B - proposal paper presented to the Institutes Guidance Executive 17 November 2014 295.09 KB

Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders 17 November 2014 36.3 KB

Macular oedema (retinal vein occlusion) - dexamethasone: equality impact assessment

Macular oedema (retinal vein occlusion) - dexamethasone: equality impact assessment 27 July 2011 68.56 KB

Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination

Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination information

Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination document 06 June 2011 247.63 KB

Response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) 06 June 2011 178.82 KB

Consultee and commentator comments on the ACD

Allergan cover letter 06 June 2011 192.77 KB

Allergen response to ACD 06 June 2011 460.43 KB

Allergan additional analysis 06 June 2011 855.46 KB

Appendices to the additional analysis 06 June 2011 735.75 KB

RNIB ACD comments 06 June 2011 57.33 KB

RCO ACD comments 06 June 2011 102.96 KB

RCN ACD comments 06 June 2011 50.89 KB

NHS Waltham Forest ACD comments 06 June 2011 287.92 KB

Comments on the ACD received from the public through the NICE website

NHS Wirrall 06 June 2011 28.68 KB

NHS Bradford and Airedale 06 June 2011 46.43 KB

Additional ERG critique post ACD by Aberdeen HTA Group 10 June 2011 1.04 MB

Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation

Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation

Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation document information

Macular oedema (retinal vein occlusion) - dexamethasone: evaluation report

Macular oedema (retinal vein occlusion) - dexamethasone: pre-meeting briefing 07 February 2011 290.48 KB

Macular oedema (retinal vein occlusion) - dexamethasone: final scope 07 February 2011 60.75 KB

Macular oedema (retinal vein occlusion) - dexamethasone: final matrix 07 February 2011 48.96 KB

Macular oedema (retinal vein occlusion) - dexamethasone: manufacturer submissions

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Allergan Pharmaceuticals 07 February 2011 7.87 MB

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Allergan Pharmaceuticals - additional analyses 07 February 2011 2.67 MB

Macular oedema (retinal vein occlusion) - dexamethasone: clarification letters

Macular oedema (retinal vein occlusion) - dexamethasone: NICE request to the manufacturer for clarification on their submission 07 February 2011 135.45 KB

Macular oedema (retinal vein occlusion) - dexamethasone: Manufacturer's response to NICE's request for clarification 07 February 2011 870.54 KB

Macular oedema (retinal vein occlusion) - dexamethasone: non-manufacturer submissions

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) 07 February 2011 60.22 KB

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study A 07 February 2011 8.62 KB

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study B 07 February 2011 36.34 KB

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study C 07 February 2011 8.69 KB

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study D 07 February 2011 10.79 KB

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Nursing 07 February 2011 60.73 KB

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Ophthalmologists 07 February 2011 118.88 KB

Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Ophthalmologists - Interim Guidelines for Management of Retinal Vein Occlusion 08 February 2011 286.67 KB

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statements

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - McLaughlan 07 February 2011 17.15 KB

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Pearce 07 February 2011 18.33 KB

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Read 07 February 2011 19.96 KB

Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Taylor 07 February 2011 11.37 KB

Macular oedema (retinal vein occlusion) - dexamethasone: evidence review group report

Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report 07 February 2011 1.47 MB

Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report - additional analyses 07 February 2011 157.77 KB

Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report - factual accuracy check 07 February 2011 65.22 KB

Macular oedema (retinal vein occlusion) - dexamethasone: final scope

Macular oedema (retinal vein occlusion) - dexamethasone: final scope 05 August 2010 60.75 KB

Macular oedema (retinal vein occlusion) - dexamethasone: final matrix

Macular oedema (retinal vein occlusion) - dexamethasone: final matrix 05 August 2010 47.58 KB

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope 05 August 2010 185.66 KB

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope 05 August 2010 42.58 KB

Appendix B: draft scope for consultation (pre-referral)

Appendix B: draft scope for consultation (pre-referral) 12 July 2010 34.16 KB

Appendix C: provisional matrix (pre-referral)

Appendix C: provisional matrix (pre-referral) 12 July 2010 30.35 KB